Smo Clinical Research (India) Private Limited, a active private limited company, was established on 30 April 2007 in Bangalore, Karnataka, India. Engaging in pharma contract r&d within the hospital and medical care sector, it holds CIN: U73100KA2007PTC042650. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.32 M.
It upholds a compliant status. Its leadership includes Jakkampudi Naga Sravani (Director), Rakshith Katta Ramanjaneya (Director), Ramanjaneya Hanumanthappa Katta (Managing Director). Past directors included Rakshith Katta Ramanjaneya. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 84, 4Th Cross U A S Layout, Sanjay Nagar, Bangalore, Karnataka, 560094.
U73100KA2007PTC042650
042650
30 April 2007
₹0.50 M
₹0.32 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Smo Clinical Research (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jakkampudi Naga Sravani | Director | 30 Apr 2007 | Current |
| Rakshith Katta Ramanjaneya | Director | 01 Mar 2024 | Current |
| Ramanjaneya Hanumanthappa Katta | Managing Director | 30 Apr 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Smo Clinical Research (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 148.79% increase. The company also saw a substantial improvement in profitability, with a 111.94% increase in profit. The company's net worth moved up by a moderate rise of 7.98%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Smo Clinical Research (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Smo Clinical Research (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Smo Clinical Research (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smo Clinical Research (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Smo Clinical Research (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Smo Clinical Research (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Rakshith Katta Ramanjaneya was appointed as a Director was appointed as a Director on 01 Mar 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
The activity Jakkampudi Naga Sravani was appointed as a Director was appointed as a Director on 30 Apr 2007 & has been associated with this company since 18 years 7 months . was completed.
The activity Ramanjaneya Hanumanthappa Katta was appointed as a Managing Director was appointed as a Managing Director on 30 Apr 2007 & has been associated with this company since 18 years 7 months . was completed.
The activity Smo Clinical Research (India) Private Limited was registered on 30 Apr 2007 with Roc Bangalore & aged 18 years 7 months as per MCA records. was completed.
The CIN of Smo Clinical Research (India) Private Limited is U73100KA2007PTC042650.
Smo Clinical Research (India) Private Limited is headquartered at 84, 4Th Cross U A S Layout, Sanjay Nagar, Bangalore, Karnataka, 560094.
Smo Clinical Research (India) Private Limited was incorporated on 30 April 2007.
The current directors of Smo Clinical Research (India) Private Limited are
The primary industry of Smo Clinical Research (India) Private Limited is Hospital And Medical Care.
Smo Clinical Research (India) Private Limited is unlisted.
The authorized capital of Smo Clinical Research (India) Private Limited is ₹0.50 M, and the paid-up capital is ₹0.32 M.
The compliance status of Smo Clinical Research (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX